文献速递瓣膜外科

持续性长程房颤外科消融术前无创标测的电生理机制研究

Noninvasive mapping before surgical ablation for persistent, long-standing atrial fibrillation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-09-25

该初步试验对10例持续性房颤患者(6例男性,平均年龄70±10岁)在合并外科手术前使用无创表面标测系统(ECVUE)进行逐搏三维标测。术前标测均成功识别房颤潜在机制,所有患者均存在双房病变、转子和大折返活动,仅6例有局灶活动,右房转子活动见于所有患者。结论认为双房机制普遍存在,支持Cox-Maze III/IV手术治疗瓣膜病房颤患者。

要点

  • 所有患者术前标测成功并识别房颤机制,双房病变普遍存在。
  • 转子和大折返活动见于所有患者,右房转子活动均被记录。
  • 双房机制提示Cox-Maze III/IV手术对非阵发性房颤患者的重要性。

核心结论

  • 所有患者均检测到房颤的双房机制,强调Cox-Maze III/IV手术治疗瓣膜性心脏病合并非阵发性房颤的重要性。
  • 术前标测有潜力显著提高对房颤病理生理的理解,并更好地指导单个患者的手术消融策略。

研究设计与样本

  • 初步试验,纳入10例持续性房颤患者(6例男性;平均年龄70±10岁),术前使用无创表面标测系统(ECVUE,CardioInsight,Medtronic Inc)进行逐搏三维标测。
  • 8例拟行二尖瓣手术,1例拟行主动脉瓣和升主动脉替换,1例拟行冠状动脉旁路移植术;5例同时行三尖瓣修复。
  • 所有患者行Cox-Maze III/IV,采用冷冻消融和双极射频联合,并切除左心耳。
  • 术前房颤中位持续时间30个月,左房直径63 mm。
  • 心房区域按Bordeaux分类划分。

主要发现

  • 术前标测在所有患者中成功,清晰识别房颤潜在机制。
  • 所有受试者均识别出双房病变。
  • 所有患者均存在转子和大折返活动,仅6例显示局灶活动。
  • 所有患者均记录到右房转子活动。

临床怎么用

  • 对于瓣膜性心脏病合并非阵发性房颤患者,术前无创标测可识别双房机制,支持行Cox-Maze III/IV手术。
  • 术前标测可能有助于个体化选择手术消融策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study objective was to study the electrophysiologic mechanism of atrial fibrillation using a noninvasive, beat-by-beat, 3-dimensional mapping technique in patients with persistent and long-standing persistent atrial fibrillation undergoing concomitant surgical ablation. METHODS: In this pilot trial, 10 patients (6 male; mean age, 70 ± 10 years) with persistent atrial fibrillation were mapped preoperatively with a noninvasive surface system (ECVUE, CardioInsight, Medtronic Inc, Minneapolis, Minn). Eight patients were candidates for mitral valve surgery, 1 patient was a candidate for aortic valve and ascending aortic replacement, and 1 patient was a candidate for coronary bypass surgery. In 5 patients, tricuspid valve repair was also performed. The Cox-Maze III/IV was performed using combined cryoablation and bipolar radiofrequency, and the left appendage was removed in all cases. The median preprocedural duration of atrial fibrillation was 30 months, and the diameter of the left atrium was 63 mm. Atrial regions were divided according to the Bordeaux classification. RESULTS: Preoperative mapping was successful in all patients with clear identification of the potential mechanism of atrial fibrillation. Biatrial pathology was recognized in all subjects. Rotor and macro re-entry activity were present in all patients, whereas focal activity was demonstrated in only 6 patients. Rotor activity in the right atrium was documented in all patients. CONCLUSIONS: This is the first report on the preoperative use of the ECUVE in surgical candidates for concomitant surgical procedures. The fact that a biatrial mechanism for atrial fibrillation was detected in all patients emphasizes the importance of a Cox-Maze III/IV procedure to treat patients with valvular heart disease and nonparoxysmal atrial fibrillation. Preoperative mapping has the potential to significantly improve our understanding of the pathophysiology in atrial fibrillation and better guide the surgical ablation procedure of choice in a single patient.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ehrlich MP, Laufer G, Coti I, et al. Noninvasive mapping before surgical ablation for persistent, long-standing atrial fibrillation. J Thorac Cardiovasc Surg. 2018. PMID: 30482525. doi:10.1016/j.jtcvs.2018.07.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。